Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
137.00    -8.00 (-5.52%)
Bid:
137.00
Ask:
144.50
Spread: 7.50 (5.474%)
Market Cap: £107.51m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Statement

19 Jan 2012 07:00

RNS Number : 8017V
Xaar PLC
19 January 2012
 



 

 

 

FOR IMMEDIATE RELEASE

19 January 2012

 

 

 

Xaar plc

 

 

YEAR END TRADING UPDATE

 

 

Xaar plc ("Xaar" or "the Group" or "the Company"), the inkjet printing technology group headquartered in Cambridge, announces an update on trading for the year ended 31 December 2011.

 

Trading for the fourth quarter of the year was slightly ahead of the Board's expectations, leading to a strong performance for the full year 2011.

 

Xaar expects to announce revenue of approximately £69 million for 2011, an increase of over 25% compared to 2010 (£54.7 million).

 

Revenue growth in 2011 was achieved mainly by increased sales into the industrial segment. Demand for Xaar's technology in this segment is principally driven by the conversion of ceramic tile printing to digital inkjet from analogue processes. During the year, Xaar made good progress with the capacity expansion programme to support this demand and the programme remains on track to continue to deliver the planned incremental capacity during the first half of 2012.

 

As expected, product sales into the graphic arts segment declined in 2011 by approximately 15% compared to 2010. As previously described, this decline reflects market maturity and competitive pressure.

 

The Group continues to maintain a strong balance sheet with net cash at 31 December 2011 of £17.4 million (30 June 2011 - £20.6 million; 31 December 2010 - £22.0 million).

 

The detailed results for 2011 are expected to be announced on 20 March 2012.

 

Board changes

 

As previously announced Phil Eaves, Sales and Marketing Director, informed the Company in 2011 of his intention to retire from full time employment in June 2012. Following an extensive search process, the Company is pleased to announce that Richard Barham has been appointed Sales and Marketing Director and member of the Xaar board with effect from 5 March 2012. After completion of a handover period, Phil Eaves will continue to support the Company in a consultant role until 30 June 2012.

 

Ian Dinwoodie, Chief Executive commented:

 

'On behalf of everyone at Xaar, I would like to thank Phil for his efforts and contribution over the last 7 years during which our revenues have grown significantly. We all wish him well for the future.

 

I am pleased to welcome Richard to the Board, who brings a wealth of experience gained through 25 years spent in numerous sectors of the Imaging and Printing industries.'

Since 1986, Mr Barham has held a range of sales, marketing and management positions at Agfa Graphics NV, where most recently, since February 2008, he acted as Vice President of the Inkjet Division where he was responsible for turning the business around and integrating a major acquisition.

 

There is no further information concerning Mr Barham which requires disclosure under rule 9.6.13 of the UK Listing Authority Listing Rules.

 

 

END

 

CONTACTS

 

Xaar plc:

01223-423663

Ian Dinwoodie, Chief Executive

www.xaar.com

Alex Bevis, Finance Director

Singer Capital Markets Limited:

020-3205-7500

Shaun Dobson

Bankside Consultants:

Simon Bloomfield

020-7367-8888 / 07771-758517

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDVLFFLFFFBBB
Date   Source Headline
26th Apr 20063:56 pmRNSDirector/PDMR Shareholding
24th Apr 20064:29 pmRNSResult of AGM
24th Apr 20067:01 amRNSAGM positive trading update
18th Apr 20066:05 pmRNSDirector/PDMR Shareholding
18th Apr 200611:31 amRNSAnnual Information Update
5th Apr 20064:59 pmRNSDirector/PDMR Shareholding
30th Mar 20065:24 pmRNSHolding(s) in Company
14th Mar 20066:21 pmRNSDirector/PDMR Shareholding
14th Mar 20067:01 amRNSFinal Results
21st Feb 20067:01 amRNSNotice of Preliminary Results
14th Feb 20065:29 pmRNSHolding(s) in Company
12th Jan 20067:00 amRNSPeriod-end trading update
29th Nov 20057:00 amRNSHolding(s) in Company
25th Nov 20051:02 pmRNSDirector/PDMR Shareholding
23rd Nov 20055:43 pmRNSDirector/PDMR Shareholding
22nd Nov 20056:30 pmRNSDirector/PDMR Shareholding
7th Nov 20057:00 amRNSAnalyst and investor seminar
3rd Nov 20056:17 pmRNSHolding(s) in Company
24th Oct 20054:13 pmRNSDirector/PDMR Shareholding
24th Oct 20054:11 pmRNSDirector/PDMR Shareholding
24th Oct 20052:47 pmRNSHolding(s) in Company
14th Oct 20056:13 pmRNSHolding(s) in Company
14th Oct 20056:05 pmRNSHolding(s) in Company
12th Oct 200512:44 pmRNSDirector/PDMR Shareholding
10th Oct 20055:22 pmRNSDirector/PDMR Shareholding
6th Oct 20057:00 amRNSHolding(s) in Company
5th Oct 200510:59 amRNSDirector/PDMR Shareholding
27th Sep 20056:11 pmRNSDirector/PDMR Shareholding
20th Sep 20051:06 pmRNSDirector/PDMR Shareholding
14th Sep 20057:02 amRNSAppointment of director
14th Sep 20057:01 amRNSInterim Results
12th Sep 20057:00 amRNSInvestment in trade partner
16th Aug 20055:51 pmRNSNotice of Interim Results
16th Aug 20052:30 pmRNSNotice of Interim Results
28th Jul 20054:32 pmRNSHolding(s) in Company
21st Jul 200510:28 amRNSHolding(s) in Company
6th Jul 20057:00 amRNSPositive half year update
4th Jul 200511:36 amRNSHolding(s) in Company
4th Jul 200511:26 amRNSDirector/PDMR Shareholding
8th Jun 20056:31 pmRNSHolding(s) in Company
2nd Jun 20054:05 pmRNSHolding(s) in Company
26th May 20054:22 pmRNSHolding(s) in Company
26th May 20052:15 pmRNSDirector Shareholding
20th May 20059:28 amRNSHolding(s) in Company
13th May 20057:01 amRNSSystems integration partner
5th May 20056:27 pmRNSHolding(s) in Company
29th Apr 200511:45 amRNSHolding(s) in Company
28th Apr 20052:30 pmRNSResult of AGM
28th Apr 20057:00 amRNSPositive AGM update
25th Apr 20055:10 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.